Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Hexagon US Federal Names Chris Reichert to the Board of Directors as the Secretary of the Government Security Committee (GSC)
-
Aruna Bio to Participate in Upcoming Investor Conferences
-
Jadex Inc. Recognized as U.S. Best-in-Class Employer by Gallagher
-
KB Home Announces the Grand Opening of Its Newest Community in Lakeland, Florida
-
MADE BY GATHER LAUNCHES REFRESHED BELLA BRAND
-
Stathera Announces the Appointment of Industry Veteran Dr. Sehat Sutardja to its Board of Directors
-
Ontario International Airport continued its run of higher passenger volumes in February
-
Gabelli Funds to Host 10th Annual Waste & Sustainability Symposium Thursday, April 4, 2024
-
Virtual Incision’s MIRA Surgical System to be Featured Among Elite AI-Enabled Innovations at NVIDIA GTC
-
MatSing Announces Support for Multiple Satellite Applications Leveraging its Innovative Lens Antenna Solutions
-
Frontier to Present at The New Street Research and BCG Fiber-to-the-Future Conference
-
Clarifai and Deepgram Announce Strategic Partnership to Accelerate AI Innovation
-
Zebra Banking Survey Finds Half of Employees May Quit Due to Outdated Tech
-
Inocras Inc. Unveils Rebranding of Genome Insight
-
A. O. Smith Appoints Stephen Shafer President and Chief Operating Officer
-
RYBREVANT® (amivantamab-vmjw) data at ELCC advance Johnson & Johnson's ambition to transform the standard of care for patients with EGFR-mutated non-small cell lung cancer
-
Improving literacy rates critical to quality of life: United for Literacy survey
-
IEEE-ISTO Announces Formation of the Waveform Architecture for Virtualized Ecosystems (WAVE) Consortium
-
Auto Parts 4 Less Group Inc. Continues to Strengthen Balance Sheet with Additional Debt Conversion
-
Copper State Credit Union Takes One Platform Approach with Jack Henry
-
Moomoo Wins "Best Stock Trading App" Award in 2024 FinTech Breakthrough Awards Program
-
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
-
NetBet Casino joins forces with 7777 gaming
-
ContextLogic Files Definitive Proxy Statement Regarding Proposed Transaction with Qoo10
-
AliveGen Announces Successful Completion of Phase 1b Multiple-Ascending Dose Clinical Trial for ALG-801
-
Semilux International Ltd. Launches Strategic R&D Collaboration Program on Solid-State Automotive LiDAR Module to Explore the Frontier in Autonomous Driving Technology
-
Auddia Announces New $3.5M Financing
-
Nano Labs Announces Second Half of 2023 Financial Results
-
Stellar Cyber Achieves Certified Integration with Trellix Endpoint Security
-
Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024
-
HireVue Joins US Artificial Intelligence Safety Institute Consortium
-
Columbus McKinnon Announces Appointment of Chris Stephens Jr. to Board of Directors
-
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
-
RevoluGROUP and eSignus: Bridging the Digital Asset Divide Through Revolutionary Integration of Digital and Fiat Payment Fabrics
-
Vislink to Report Full Year and Fourth Quarter 2023 Financial Results on Monday, April 1, 2024, at 8:30 a.m. ET
-
WORKSPORT ANNOUNCES PRICING OF APPROXIMATELY $2.8 MILLION REGISTERED DIRECT OFFERING & CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
-
VoIP-Pal Announces Three New Special Advisor Appointments
-
Sacks Parente Golf, Inc. Announces Year End 2023 Financial Results and Provides Corporate Update
-
Apple Jing’an to welcome its first customers this Thursday, March 21, in Shanghai
-
Inspired Entertainment Provides Update on Fourth Quarter and Year End Reporting Timeline
-
Inovalon Announces Converged Submissions To Support Health Plan Risk Adjustment Programs
-
Kratos Receives $57.6 Million Contract for 70 BQM-177A Aerial Targets
-
Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects
-
Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma
-
Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
-
Chimney Surpasses 65 Credit Unions with its Growing Client Base
-
Gabelli Funds to Host 10th Annual Waste & Sustainability Symposium Thursday, April 4, 2024
-
Duos Technologies Group Sets Fourth Quarter and Full Year 2023 Earnings Call for Monday, April 1, 2024 at 4:30 PM ET
-
Sunrise Mountain Partners and CleanCapital Expand Development Activities
-
Panostaja's Investment Company Grano Ends Change Negotiations
